UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study

International journal of radiation oncology, biology, physics, 2009-11, Vol.75 (3), p.677-682

2009

Volltextzugriff (PDF)

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial

Journal of clinical oncology, 2019-05, Vol.37 (15), p.1316-1325

2019

Volltextzugriff (PDF)

Targeted iron oxide nanoparticles for the enhancement of radiation therapy

Biomaterials, 2016-10, Vol.105, p.127-135

2016

Volltextzugriff (PDF)

Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2019-04, Vol.103 (5), p.1077-1084

2019

Volltextzugriff (PDF)

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937

Journal of thoracic oncology, 2017-10, Vol.12 (10), p.1561-1570

2017

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial

JAMA oncology, 2018-09, Vol.4 (9), p.1263

2018

Volltextzugriff (PDF)

Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I study

International journal of radiation oncology, biology, physics, 2005-11, Vol.63 (4), p.1010-1015

2005

Volltextzugriff (PDF)

Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature

International journal of radiation oncology, biology, physics, 2019-07, Vol.104 (3), p.582-589

2019

Volltextzugriff (PDF)

Stereotactic body radiation therapy: a novel treatment modality

Nature reviews. Clinical oncology, 2010-01, Vol.7 (1), p.44-54

2010

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy Can Be Used Safely to Boost Residual Disease in Locally Advanced Non-Small Cell Lung Cancer: A Prospective Study

International journal of radiation oncology, biology, physics, 2013-04, Vol.85 (5), p.1325-1331

2013

Volltextzugriff (PDF)

Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer

Journal of clinical oncology, 2006-10, Vol.24 (30), p.4833-4839

2006

Volltextzugriff (PDF)

Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer

European journal of pharmaceutical sciences, 2013-07, Vol.49 (4), p.699-711

2013

Volltextzugriff (PDF)

Extensive-Stage Small Cell Lung Cancer: Is Consolidative Thoracic Radiation Therapy Really a New Standard of Care?

International journal of radiation oncology, biology, physics, 2015-09, Vol.93 (1), p.10-12

McGarry, Ronald C., MD, PhD

2015

Volltextzugriff (PDF)

Development and clinical validation of a robust knowledge‐based planning model for stereotactic body radiotherapy treatment of centrally located lung tumors

Journal of applied clinical medical physics, 2021-01, Vol.22 (1), p.146-155

2021

Volltextzugriff (PDF)

Clinical evaluation of photon optimizer (PO) MLC algorithm for stereotactic, single-dose of VMAT lung SBRT

Medical dosimetry : official journal of the American Association of Medical Dosimetrists, 2020-01, Vol.45 (4), p.321-326

2020

Volltextzugriff (PDF)

Reports on the Death of Whole Brain Radiation Therapy Are Greatly Exaggerated

International journal of radiation oncology, biology, physics, 2017-12, Vol.99 (5), p.1067-1070

2017

Volltextzugriff (PDF)

Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5755-5760

2008

Volltextzugriff (PDF)

Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2017-11, Vol.99 (3), p.652-659

2017

Volltextzugriff (PDF)

Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment

Radiation research, 2016-02, Vol.185 (2), p.169-181

2016

Volltextzugriff (PDF)

Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics

International journal of oncology, 2016-04, Vol.48 (4), p.1701-1709

2016

Volltextzugriff (PDF)

Dose–Volume Analysis of Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated With Concurrent Cisplatinum and Etoposide With or Without Consolidation Docetaxel

International journal of radiation oncology, biology, physics, 2010-12, Vol.78 (5), p.1381-1386

2010

Volltextzugriff (PDF)

In Reply to Hurmuz et al

International journal of radiation oncology, biology, physics, 2018-03, Vol.100 (4), p.1080-1080

2018

Volltextzugriff (PDF)

Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy

Frontiers in oncology, 2017-09, Vol.7, p.197-197

2017

Volltextzugriff (PDF)

Flattening filter free VMAT for a stereotactic, single‐dose of 30 Gy to lung lesion in a 15‐min treatment slot

Journal of applied clinical medical physics, 2020-04, Vol.21 (4), p.6-12

2020

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Englisch
(151)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(87)
Humans
(65)
Oncology
(44)
Male
(32)
Radiology, Nuclear Medicine & Medical Imaging
(32)
Middle Aged
(29)
Female
(27)
Biological And Medical Sciences
(26)
Aged
(24)
Medical Sciences
(24)
Radiotherapy
(24)
Lung Cancer
(23)
Lung Neoplasms - Pathology
(22)
Tumors
(20)
Aged, 80 And Over
(18)
Lung Neoplasms - Radiotherapy
(16)
Patients
(16)
Radiation Therapy
(16)
Carcinoma, Non-Small-Cell Lung - Pathology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial

Targeted iron oxide nanoparticles for the enhancement of radiation therapy

Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937

Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial

Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I study

Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature

Stereotactic body radiation therapy: a novel treatment modality

Stereotactic Body Radiation Therapy Can Be Used Safely to Boost Residual Disease in Locally Advanced Non-Small Cell Lung Cancer: A Prospective Study

Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer

Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer

Extensive-Stage Small Cell Lung Cancer: Is Consolidative Thoracic Radiation Therapy Really a New Standard of Care?

Development and clinical validation of a robust knowledge‐based planning model for stereotactic body radiotherapy treatment of centrally located lung tumors

Clinical evaluation of photon optimizer (PO) MLC algorithm for stereotactic, single-dose of VMAT lung SBRT

Reports on the Death of Whole Brain Radiation Therapy Are Greatly Exaggerated

Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology

Multi‐institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non–small cell lung tumors

Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer

Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment

Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics

Dose–Volume Analysis of Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated With Concurrent Cisplatinum and Etoposide With or Without Consolidation Docetaxel

In Reply to Hurmuz et al

Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy

Flattening filter free VMAT for a stereotactic, single‐dose of 30 Gy to lung lesion in a 15‐min treatment slot

Suchergebnisse filtern